Specific effects of fibrinogen and the γa and γ′-chain fibrinogen variants on angiogenesis and wound healing

Tissue Engineering - Part A

Volumn 21, Issue 1-2, 2015, Pages 106-114

  Cheung, Elim Y L ^a   Weijers, Ester M ^b   Tuk, Bastiaan ^a   Scheffer, Reinilde ^a   Leebeek, Frank W ^a   Van Neck, Johan W ^a   Koolwijk, Pieter ^b   De Maat, Moniek P M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

REPAIR;

ANGIOGENESIS; FIBRIN MATRIX; FIBRIN NETWORK; SPECIFIC EFFECTS; TISSUE REPAIR; TOPICAL APPLICATION; WOUND HEALING; WOUND HEALING PROCESS;

TISSUE REGENERATION;

CD34 ANTIGEN; FIBRIN; FIBRINOGEN; FIBRINOGEN VARIANT; GAMMA A FIBRIN; GAMMA A FIBRINOGEN; GAMMA' CHAIN FIBRIN; GAMMA' CHAIN FIBRINOGEN; PLACEBO; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT; FIBRINOPEPTIDES GAMMA;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; REVASCULARIZATION; SKIN INJURY; WOUND CLOSURE; WOUND HEALING; YOUNG ADULT; ANIMAL; CELL MOTION; CONFOCAL MICROSCOPY; DRUG EFFECTS; METABOLISM; PATHOLOGY; SKIN; UMBILICAL VEIN ENDOTHELIAL CELL;

RATTUS;

ANIMALS; ANTIGENS, CD34; CELL MOVEMENT; FIBRINOGEN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; MALE; MICROSCOPY, CONFOCAL; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; SKIN; WOUND HEALING;

EID: 84921417183     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2014.0020     Document Type: Article

References (28)

1. Doolittle, R.F. Fibrinogen and fibrin. Sci Am 245, 126, 1981.
2. Cheung, E.Y., Vos, H.L., Kruip, M.J., den Hertog, H.M., Jukema, J.W., and de Maat, M.P. Elevated fibrinogen gamma' ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome. Blood 114, 4603, 2009.
3. Uitte de Willige, S., Standeven, K.F., Philippou, H., and Ariens, R.A. The pleiotropic role of the fibrinogen gamma' chain in hemostasis. Blood 114, 3994, 2009.
4. Mosesson, M.W. Update on antithrombin I (fibrin). Thromb Haemost 98, 105, 2007.
5. Peerschke, E.I., Francis, C.W., and Marder, V.J. Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length. Blood 67, 385, 1986.
6. Cooper, A.V., Standeven, K.F., and Ariens, R.A. Fibrino-gen gamma-chain splice variant gamma' alters fibrin formation and structure. Blood 102, 535, 2003.
7. Siebenlist, K.R., Mosesson, M.W., Hernandez, I., Bush, L.A., Di Cera, E., Shainoff, J.R., Di Orio, J.P., and Stojanovic, L. Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains. Blood 106, 2730, 2005.
8. Gersh, K.C., Nagaswami, C., Weisel, J.W., and Lord, S.T. The presence of gamma' chain impairs fibrin polymerization. Thromb Res 124, 356, 2009.
9. Collet, J.P., Nagaswami, C., Farrell, D.H., Montalescot, G., and Weisel, J.W. Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate. Arterioscler Thromb Vasc Biol 24, 382, 2004.
10. Farrell, D.H. Pathophysiologic roles of the fibrinogen gamma chain. Curr Opin Hematol 11, 151, 2004.
11. Singer, A.J., and Clark, R.A. Cutaneous wound healing. N Engl J Med 341, 738, 1999.
12. Kaijzel, E.L., Koolwijk, P., van Erck, M.G., van Hinsbergh, V.W., and de Maat, M.P. Molecular weight fibrinogen variants determine angiogenesis rate in a fibrin matrix in vitro and in vivo. J Thromb Haemost 4, 1975, 2006.
13. Weijers, E.M., van Wijhe, M.H., Joosten, L., Horrevoets, A.J., de Maat, M.P., van Hinsbergh, V.W., and Koolwijk, P. Molecular weight fibrinogen variants alter gene expression and functional characteristics of human endothelial cells. J Thromb Haemost 8, 2800, 2010.
14. Martino, M.M., Briquez, P.S., Ranga, A., Lutolf, M.P., and Hubbell, J.A. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci USA 110, 4563, 2013.
15. Siebenlist, K.R., Meh, D.A., and Mosesson, M.W. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains. Biochemistry 35, 10448, 1996.
16. Ajjan, R., Lim, B.C., Standeven, K.F., Harrand, R., Dolling, S., Phoenix, F., Greaves, R., Abou-Saleh, R.H., Connell, S., Smith, D.A., Weisel, J.W., Grant, P.J., and Ariens, R.A. Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibri-nolysis and clot rigidity. Blood 111, 643, 2008.
17. van Nieuw Amerongen, G.P., Koolwijk, P., Versteilen, A., and van Hinsbergh, V.W. Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb Vasc Biol 23, 211, 2003.
18. Van Hinsberg, V.W., Sprengers, E.D., and Kooistra, T. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb Haemost 57, 148, 1987.
19. Koolwijk, P., van Erck, M.G., de Vree, W.J., Vermeer, M.A., Weich, H.A., Hanemaaijer, R., and van Hinsbergh, V.W. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human micro-vascular endothelial cells in a fibrin matrix. Role of uro-kinase activity. J Cell Biol 132, 1177, 1996.
20. Koppert, P.W., Hoegee-de Nobel, E., and Nieuwenhuizen, W. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma. Thromb Haemost 59, 310, 1988.
21. Tong, M., Zbinden, M.M., Hekking, I.J., Vermeij, M., Barritault, D., and van Neck, J.W. RGTA OTR 4120, a he-paran sulfate proteoglycan mimetic, increases wound breaking strength and vasodilatory capability in healing rat full-thickness excisional wounds. Wound Repair Regen 16, 294, 2008.
22. Tong, M., Tuk, B., Hekking, I.M., Vermeij, M., Barritault, D., and van Neck, J.W. Stimulated neovascularization, inflammation resolution and collagen maturation in healing rat cutaneous wounds by a heparan sulfate glycosaminoglycan mimetic, OTR4120. Wound Repair Regen 17, 840, 2009.
23. Tong, M., Tuk, B., Hekking, I.M., Pleumeekers, M.M., Boldewijn, M.B., Hovius, S.E., and van Neck, J.W. Heparan sulfate glycosaminoglycan mimetic improves pressure ulcer healing in a rat model of cutaneous ischemia-reperfusion injury. Wound Repair Regen 19, 505, 2011.
24. Tong, M., Tuk, B., Shang, P., Hekking, I.M., Fijneman, E.M., Guijt, M., Hovius, S.E., and van Neck, J.W. Diabetes-impaired wound healing is improved by matrix therapy with heparan sulfate glycosaminoglycan mimetic OTR4120 in rats. Diabetes 61, 2633, 2012.
25. Cheresh, D.A., Berliner, S.A., Vicente, V., and Ruggeri, Z.M. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 58, 945, 1989.
26. Thiagarajan, P., Rippon, A.J., and Farrell, D.H. Alternative adhesion sites in human fibrinogen for vascular endothelial cells. Biochemistry 35, 4169, 1996.
27. Kroon, M.E., Koolwijk, P., van Goor, H., Weidle, U.H., Collen, A., van der Pluijm, G., and van Hinsbergh, V.W. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices. Am J Pathol 154, 1731, 1999.
28. Frank, S., Hubner, G., Breier, G., Longaker, M.T., Green-halgh, D.G., and Werner, S. Regulation of vascular endo-thelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 270, 12607, 1995.